Evidence map›Paper›PMID 19533127›Full record

ReviewSeminars in immunopathology2009

The immunopathology of human biliary cell epithelium.

Ya-Hui Chuang, Ruth Y Lan, M Eric Gershwin

Abstract readReview
PubMed Publisher
In one paragraph

Review in Seminars in immunopathology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Animal models of biliary injury and altered bile acid metabolism.Biochimica et biophysica acta. Molecular basis of disease · 2018
    Review
  6. Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.Biochimica et biophysica acta. Molecular basis of disease · 2018
    Review
  7. Article
  8. Review
  9. Adaptive immunity in the liver.Cellular & molecular immunology · 2016
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Advances in cholangiocyte immunobiology.American journal of physiology. Gastrointestinal and liver physiology · 2012
    Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ya-Hui ChuangDepartment of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan. yahuichuang@ntu.edu.tw
Ruth Y Lan
M Eric Gershwin
University of California, Davis · USNational Taiwan University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bile ducts lined with biliary epithelial cells, or cholangiocytes, are the main components of the biliary system in liver. Cholangiocytes participate in the production and transport of bile substances, as well as participate in immune responses. Cholangiocytes protect against pathogens by expressing toll-like receptors and anti-microbial peptides; act as antigen-presenting cells by expressing human leukocyte antigen molecules and costimulatory molecules; recruit leukocytes to the target site by expressing adhesion molecules, cytokines, and chemokines; and induce apoptosis of leukocytes to limit the immune responses. Several cholangiopathies result from dysfunctions of the biliary system. They can broadly be divided into autoimmune, genetic, infectious, drug, and ischemic-injury-induced categories. The pathogenesis of many of these cholangiopathies is unclear and treatment is limited. Further understanding of the complexity of the biliary system is critical for medical advancements in this field.

Indexed as

Antigen PresentationAntimicrobial Cationic PeptidesApoptosisBiliary TractBiliary Tract DiseasesCell Adhesion MoleculesCytokinesEpitheliumHumansImmunoglobulin A, SecretoryLiverToll-Like ReceptorsAntimicrobial Cationic PeptidesCell Adhesion MoleculesCytokinesImmunoglobulin A, SecretoryToll-Like Receptors

Identifiers

PMID19533127
OpenAlexW2077276969

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.